Dr David Solomon joins Zealand Pharma
This article was originally published in Scrip
Zealand Pharma (Denmark) has named Dr David Solomon chief executive officer. Most recently, Dr Solomon served as chief operating officer of Vital Sensors. He has experience in pharmacology research, having served as a faculty member at Columbia University's College of Physicians and Surgeons in New York, as well as leadership positions at several biotechnology, pharmaceutical and medical device companies, including Remedy Pharmaceuticals and Critical Diagnostics.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.